Bioburden Testing Market
According to Intent Market Research, the Bioburden Testing Market is expected to grow from USD 1.1 billion in 2023 at a CAGR of 15.2% to touch USD 3.0 billion by 2030. The Bioburden Testing Market is dominated by key players such as Thermo Fisher Scientific, Merck Group, Danaher Corporation, bioMérieux SA, Charles River Laboratories, Eppendorf AG, Pall Corporation (Danaher), 3M Company, Sartorius AG, Lonza Group, Abbott Laboratories, IDEXX Laboratories, Shimadzu Corporation, Agilent Technologies, HiMedia Laboratories.